Pritumumab

Jump to: navigation, search
Pritumumab
Monoclonal antibody
Type?
SourceTemplate:Infobox drug/mab source
Identifiers
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Pritumumab

Articles

Most recent articles on Pritumumab

Most cited articles on Pritumumab

Review articles on Pritumumab

Articles on Pritumumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pritumumab

Images of Pritumumab

Photos of Pritumumab

Podcasts & MP3s on Pritumumab

Videos on Pritumumab

Evidence Based Medicine

Cochrane Collaboration on Pritumumab

Bandolier on Pritumumab

TRIP on Pritumumab

Clinical Trials

Ongoing Trials on Pritumumab at Clinical Trials.gov

Trial results on Pritumumab

Clinical Trials on Pritumumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pritumumab

NICE Guidance on Pritumumab

NHS PRODIGY Guidance

FDA on Pritumumab

CDC on Pritumumab

Books

Books on Pritumumab

News

Pritumumab in the news

Be alerted to news on Pritumumab

News trends on Pritumumab

Commentary

Blogs on Pritumumab

Definitions

Definitions of Pritumumab

Patient Resources / Community

Patient resources on Pritumumab

Discussion groups on Pritumumab

Patient Handouts on Pritumumab

Directions to Hospitals Treating Pritumumab

Risk calculators and risk factors for Pritumumab

Healthcare Provider Resources

Symptoms of Pritumumab

Causes & Risk Factors for Pritumumab

Diagnostic studies for Pritumumab

Treatment of Pritumumab

Continuing Medical Education (CME)

CME Programs on Pritumumab

International

Pritumumab en Espanol

Pritumumab en Francais

Business

Pritumumab in the Marketplace

Patents on Pritumumab

Experimental / Informatics

List of terms related to Pritumumab

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Pritumumab is a human monoclonal antibody and which it is used to treat cancer.

Cost Effectiveness of Pritumumab

| group5 = Clinical Trials Involving Pritumumab | list5 = Ongoing Trials on Pritumumab at Clinical Trials.govTrial results on PritumumabClinical Trials on Pritumumab at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Pritumumab | list6 = US National Guidelines Clearinghouse on PritumumabNICE Guidance on PritumumabNHS PRODIGY GuidanceFDA on PritumumabCDC on Pritumumab


| group7 = Textbook Information on Pritumumab | list7 = Books and Textbook Information on Pritumumab


| group8 = Pharmacology Resources on Pritumumab | list8 = AND (Dose)}} Dosing of PritumumabAND (drug interactions)}} Drug interactions with PritumumabAND (side effects)}} Side effects of PritumumabAND (Allergy)}} Allergic reactions to PritumumabAND (overdose)}} Overdose information on PritumumabAND (carcinogenicity)}} Carcinogenicity information on PritumumabAND (pregnancy)}} Pritumumab in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Pritumumab


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Pritumumab | list9 = AND (pharmacogenomics)}} Genetics of PritumumabAND (pharmacogenomics)}} Pharmacogenomics of PritumumabAND (proteomics)}} Proteomics of Pritumumab


| group10 = Newstories on Pritumumab | list10 = Pritumumab in the newsBe alerted to news on PritumumabNews trends on Pritumumab


| group11 = Commentary on Pritumumab | list11 = Blogs on Pritumumab

| group12 = Patient Resources on Pritumumab | list12 = Patient resources on PritumumabDiscussion groups on PritumumabPatient Handouts on PritumumabDirections to Hospitals Treating PritumumabRisk calculators and risk factors for Pritumumab


| group13 = Healthcare Provider Resources on Pritumumab | list13 = Symptoms of PritumumabCauses & Risk Factors for PritumumabDiagnostic studies for PritumumabTreatment of Pritumumab

| group14 = Continuing Medical Education (CME) Programs on Pritumumab | list14 = CME Programs on Pritumumab

| group15 = International Resources on Pritumumab | list15 = Pritumumab en EspanolPritumumab en Francais

| group16 = Business Resources on Pritumumab | list16 = Pritumumab in the MarketplacePatents on Pritumumab

| group17 = Informatics Resources on Pritumumab | list17 = List of terms related to Pritumumab


}}



Linked-in.jpg